Back to Journals » Clinical Ophthalmology » Volume 7

Prophylactic postoperative ketorolac improves outcomes in diabetic patients assigned for cataract surgery

Authors Elsawy MF, Badawi N, Khairy HA

Received 15 October 2012

Accepted for publication 6 May 2013

Published 24 June 2013 Volume 2013:7 Pages 1245—1249

DOI https://doi.org/10.2147/OPTH.S39188

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 3

Moataz F Elsawy, Nermine Badawi, Hany A Khairy

Ophthalmology Department, Menoufia University Hospital, Menoufia, Egypt

Objective: To evaluate the prophylactic role of topical non-steroidal anti-inflammatory drugs in reducing the incidence of central macular edema (CME) in diabetic eyes post-cataract surgery.
Patients and methods: This study included 86 eyes (70 patients) with high risk characteristics for the development of CME after cataract surgery. All patients underwent phacoemulsification and intraocular lens implantation. Patients were divided into two equal groups (n = 43 [eyes]): a control group given topical dexamethasone 0.1%, four times/day for 12 weeks postoperatively and a study group given topical ketorolac tromethamine 0.4% twice daily in addition to topical dexamethasone 0.1% four times daily for 12 weeks. Patients were examined at 3, 6, and 12 weeks postoperatively for evaluation of CME development. The main study outcome was the change in the retinal fovea thickness measured with ocular coherence topography.
Results: Ten eyes developed CME (11.6%); eight eyes in the control group and only two eyes in the study group. Mean retinal fovea thickness was significantly higher in the control group compared to the study group. Moreover, eyes of the control group developed CME significantly earlier than those of the study group.
Conclusion: Prophylactic postoperative ketorolac 0.4% may have a role in reducing the frequency and severity of CME in diabetic eyes post-cataract surgery.

Keywords: diabetes mellitus, cataract surgery, central macular edema, ketorolac, dexamethasone

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]